New Tool to Identify and Control Neurons

Since scientists began studying the brain, they have asked whether the biology they observed can really be tied to external behaviors. Researchers are building a substantial understanding of the biophysical, molecular, and cellular interactions of neurons, but directly relating those interactions to outward behaviors is an ongoing challenge in the field. “The biophysical properties of neurons are pretty well known,” said Hyungbae Kwon, Ph.D., Research Group Leader at the Max Planck Florida Institute for Neuroscience (MPFI). “What we don’t know well is how these connections and communications trigger our behavior.”

MORE “New Tool to Identify and Control Neurons”

MODERNIZING MEDICINE ANNOUNCES AGREEMENT WITH COVERMYMEDS FOR ELECTRONIC PRIOR AUTHORIZATION

CoverMyMeds, a leader in electronic prior authorization (ePA) solutions, and Modernizing Medicine, the specialty-specific health IT leader, today announced an agreement to bring electronic prior authorization (ePA) functionality to the over 7,500 providers using EMA™, the award winning electronic health record (EHR) system in Modernizing Medicine’s suite of services.

MORE “MODERNIZING MEDICINE ANNOUNCES AGREEMENT WITH COVERMYMEDS FOR ELECTRONIC PRIOR AUTHORIZATION”

Scripps Florida Scientist and Collaborators Win $7 Million Grant to Develop New ALS Treatments

Professor Matthew Disney of the Department of Chemistry on the Florida campus of The Scripps Research Institute (TSRI), together with scientists from Mayo Clinic’s Florida campus and Johns Hopkins School of Medicine, has been awarded $7.2 million from the National Institute of Neurological Disorders and Stroke of The National Institutes of Health to create new RNA-based treatments for the most common form of amyotrophic lateral sclerosis (ALS), as well as a type of frontotemporal dementia (FTD).

MORE “Scripps Florida Scientist and Collaborators Win $7 Million Grant to Develop New ALS Treatments”